Data: CDC; Note: 2020 value based on responses collected 2017–2020; Chart: Axios Visuals
The obesity rate in the U.S. has stopped climbing — a remarkable trend shift after decades of growth, Axios' Caitlin Owens reports.
It may even be declining, but the change is too small to say for sure. Either way, it's good news.
💡 The big picture: In the last few years a sea change has occurred in how obesity is understood, with the focus shifting away from personal willpower toward seeing obesity as a disease.
And with the emergence of drugs like Ozempic, the U.S. has tools that could eventually help bring obesity rates down.
🩺 Yes, but: Severe obesity has been rising, reaching a rate of nearly 10% of U.S. adults, according to recent CDC data.
Just over 40% of adults are considered obese — still an alarmingly high rate, given the condition's health risks.
🔮 What we're watching: New anti-obesity drugs are remarkably effective, but their success in lowering the obesity rate will depend on how many people end up having access to them.
Current prices are prohibitive for many insurers, businesses and government payers.